Not applicableUnknownNCT02992990What this trial is testingBladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and GradeWho this might be right forBladder Cancer Baylor College of Medicine 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03022825What this trial is testingQUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder CancerWho this might be right forBladder Cancer ImmunityBio, Inc. 190
Testing effectiveness (Phase 2)Study completedNCT04383743What this trial is testingPembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder CancerWho this might be right forStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma University of Washington 17
Testing effectiveness (Phase 2)UnknownNCT05957757What this trial is testingRC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 ExpressionWho this might be right forNon-Muscle Invasive Bladder CancerHER2 RenJi Hospital 20
Not applicableUnknownNCT05626101What this trial is testingSafety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized StudyWho this might be right forNon-muscle-invasive Bladder Cancer Al-Azhar University 280
Testing effectiveness (Phase 2)Study completedNCT00393809What this trial is testingSafety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder CancerWho this might be right forBladder Neoplasms Hebrew University of Jerusalem 18
Not applicableAvailableNCT06443944What this trial is testingAn Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGWho this might be right forNon-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more CG Oncology, Inc.
Early research (Phase 1)WithdrawnNCT04109092What this trial is testingStimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102Who this might be right forUrinary Bladder Neoplasms Eisai Inc.
Not applicableWithdrawnNCT04583553What this trial is testingComparative Microbial Analysis of Cystitis in Non-muscle-invasive Bladder Cancer Patients Using Vikor Scientific Urine-ID Testing Menu (IDTM) and Standard Laboratory CultureWho this might be right forUrinary Tract InfectionsBladder Cancer University of Kansas Medical Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06227065What this trial is testingPrecise Neoadjuvant Chemoresection of Low Grade NMIBCWho this might be right forBladder CancerNon-muscle Invasive Bladder CancerLow-risk University of Bern 28
Testing effectiveness (Phase 2)Study completedNCT00002917What this trial is testingPaclitaxel in Treating Patients With Early-Stage Bladder CancerWho this might be right forBladder Cancer Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Testing effectiveness (Phase 2)Active Not RecruitingNCT04375813What this trial is testingTrial of Encapsulated Rapamycin (eRapa) for Bladder Cancer PreventionWho this might be right forNon-muscle Invasive Bladder Cancer Robert Svatek 166
Testing effectiveness (Phase 2)UnknownNCT02070120What this trial is testingInvestigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder CancerWho this might be right forBladder Cancer Institute of Cancer Research, United Kingdom 82
Early research (Phase 1)UnknownNCT03421236What this trial is testingIntravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)Who this might be right forNon Muscle Invasive Bladder Cancer Patrice Jichlinski 25
Large-scale testing (Phase 3)Looking for participantsNCT06929286What this trial is testingA Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)Who this might be right forNon-Muscle Invasive Bladder Cancer Memorial Sloan Kettering Cancer Center 125
Large-scale testing (Phase 3)Study completedNCT07279792What this trial is testingImplications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral ResectionWho this might be right forBladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more Ain Shams University 150
Large-scale testing (Phase 3)WithdrawnNCT07551544What this trial is testingANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder CancerWho this might be right forNMIBC ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT03892642What this trial is testingAvelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder CancerWho this might be right forBladder Cancer University of Oklahoma 18
Not applicableEnded earlyNCT04142359What this trial is testingPK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)Who this might be right forPharmacokinetics Altor BioScience 1
Not applicableActive Not RecruitingNCT07252297What this trial is testingThe Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder CancerWho this might be right forNon-muscle Invasive Bladder Cancer Xijing Hospital 177